Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessment of Prognostic Factors in 102 Patients with Myelodysplastic Syndrome-Osteoblasts are Related to Survival.

Hematology (Amsterdam, Netherlands)·2016

Same author

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes.

Leukemia·2016

Same author

Ikaros family transcription factors expression in rat thymus: detection of impaired development.

International journal of immunopathology and pharmacology·2013

Same author

Reverse transcriptase-polymerase chain reaction (rt-PCR).

Methods in molecular medicine·2011

Same author

Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus.

Scandinavian journal of immunology·2010

Same author

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.

Leukemia·2010

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Prolegomenon for chronic lymphocytic leukaemia.

B Vitale¹, M Martinis, M Antica

¹Department of Molecular Medicine, Merkur University Hospital, Zagreb, Croatia. vitale@rudjer.irb.hr

Scandinavian Journal of Immunology

|November 26, 2003

Summary

Chronic lymphocytic leukemia (CLL) may stem from age-related thymic dysfunction, impacting T and B cell maturation. This primary immunodeficiency in the elderly facilitates malignant B-cell clone emergence and disease progression.

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Experiment Videos

Last Updated: Jul 24, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Area of Science:

Immunology
Hematology
Oncology

Background:

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy primarily affecting the elderly.
CLL is characterized by immune defects, leading to infections, autoimmune disorders, and impaired tumor surveillance.
The incidence of CLL increases with age, suggesting a link to age-dependent biological processes.

Purpose of the Study:

To investigate the hypothesis that CLL arises from age-related functional restrictions in the thymic microenvironment.
To explore the role of T-cell dysregulation and genetic abnormalities in B-cell progenitors in CLL pathogenesis.
To understand how these factors contribute to the emergence and clinical evolution of the malignant B-cell clone.

Main Methods:

The study proposes a theoretical framework based on existing literature and immunological principles.
It integrates concepts of thymic microenvironment function, lymphoid progenitor differentiation, and B-cell genetics.
Analysis focuses on the interplay between T-cell subsets, B-cell oncogenes, and cytokine production in CLL.

Main Results:

Age-dependent thymic restrictions impair the differentiation of common lymphoid progenitors (CD5+ME+CD4-CD8-) into mature T and B cells.
Genetic abnormalities in B-cell progenitors (Pgp+) combined with altered T-cell populations contribute to malignant clone emergence.
Imbalances in T-cell interactions and cytokines deregulate oncogenes (c-myc, p53, bcl-2), promoting B-cell proliferation and hindering differentiation.

Conclusions:

CLL can be viewed as a primary immunodeficiency syndrome in the elderly.
The underlying cause is the age-related decline in thymic function, leading to irregular maturation of lymphoid progenitor cells.
This process, coupled with genetic factors, facilitates the development and progression of the malignant CD5+ME+ B-cell clone.